Radiopharm Theranostics Limited (ASX:RAD)
0.0220
-0.0010 (-4.55%)
Jul 16, 2025, 3:58 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 52.03 million as of July 15, 2025. Its market cap has increased by 29.47% in one year.
Market Cap
52.03M
Enterprise Value
14.39M
Revenue
330.63K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 52.03M, a decrease of -48.66%. That is a compound annual growth rate of -16.74%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 15, 2025 | 52.03M | -1.17% |
Dec 31, 2024 | 52.65M | 91.43% |
Dec 29, 2023 | 27.50M | -20.28% |
Dec 30, 2022 | 34.50M | -65.53% |
Dec 31, 2021 | 100.07M | -1.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 116.99B |
Pro Medicus | 33.92B |
Cochlear | 19.67B |
Sonic Healthcare | 13.48B |
Ramsay Health Care | 8.77B |
Telix Pharmaceuticals | 7.94B |
Ansell | 4.35B |
Regis Healthcare | 2.20B |